Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

NCT04026997 ·Status: TERMINATED ·Phase: PHASE2

Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

NCT02500732 ·Status: COMPLETED ·Phase: PHASE2

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

NCT00981487 ·Status: COMPLETED ·Phase: PHASE1

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions

NCT00946387 ·Status: COMPLETED ·Phase: PHASE1

Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department

NCT00590317 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

NCT02045901 ·Status: TERMINATED ·Phase: PHASE4

Study of Ondansetron in the Prevention of Sleep Syncope: The Nineth Prevention of Syncope Trial (POST9)

NCT05657925 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

the Efficacy and Safety of Ondansetron Oral Soluble Pellicles

NCT06282211 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis

NCT02699385 ·Status: TERMINATED ·Phase: PHASE3

Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial

NCT01149369 ·Status: COMPLETED ·Phase: PHASE2

Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan

NCT01870648 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

NCT01578252 ·Status: COMPLETED ·Phase: PHASE1

To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions

NCT00947128 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Different Oral Rehydration Solutions

NCT02142582 ·Status: COMPLETED ·Phase: NA

A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)

NCT00394966 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

NCT02357420 ·Status: COMPLETED ·Phase: PHASE2

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

NCT01262898 ·Status: COMPLETED ·Phase: PHASE2

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

NCT00642512 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

NCT06543966 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Effects of Oxybutynin Topical Gel on Gastric Emptying

NCT00926926 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

NCT00733551 ·Status: COMPLETED ·Phase: PHASE1

Open-label, Normal Healthy Volunteer Clinical Trial of a Novel Ondansetron Formulation

NCT01290276 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

NCT05832151 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

NCT06899217 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)

NCT00990821 ·Status: COMPLETED ·Phase: PHASE1